These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Affinity of penicillin-binding proteins of Escherichia coli K-12 for furbenicillin and other beta-lactam antibiotics]. Lei Y, Li JT. Zhongguo Yao Li Xue Bao; 1989 Mar; 10(2):177-80. PubMed ID: 2683579 [Abstract] [Full Text] [Related]
28. Competition of beta-lactam antibiotics for the penicillin-binding proteins of Neisseria gonorrhoeae. Dougherty TJ, Koller AE, Tomasz A. Antimicrob Agents Chemother; 1981 Jul; 20(1):109-14. PubMed ID: 6792979 [Abstract] [Full Text] [Related]
31. Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli. Evans ME, Pollack M. J Infect Dis; 1993 Jun; 167(6):1336-43. PubMed ID: 8501323 [Abstract] [Full Text] [Related]
32. Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus. Hayes MV, Orr DC. J Antimicrob Chemother; 1983 Aug; 12(2):119-26. PubMed ID: 6413485 [Abstract] [Full Text] [Related]
33. Target affinities of faropenem to and its impact on the morphology of gram-positive and gram-negative bacteria. Dalhoff A, Nasu T, Okamoto K. Chemotherapy; 2003 Jul; 49(4):172-83. PubMed ID: 12886052 [Abstract] [Full Text] [Related]
34. Cefotaxime: binding affinity to penicillin-binding proteins and morphological changes of Escherichia coli and Pseudomonas aeruginosa. Masuyoshi S, Inoue M, Takaoka M, Mitsuhashi S. Arzneimittelforschung; 1981 Jul; 31(7):1070-2. PubMed ID: 6268122 [Abstract] [Full Text] [Related]
35. Antibacterial and pharmacokinetic properties of M14659, a new injectable semisynthetic cephalosporin. Mochizuki H, Oikawa Y, Yamada H, Kusakabe S, Shiihara T, Murakami K, Kato K, Ishiguro J, Kosuzume H. J Antibiot (Tokyo); 1988 Mar; 41(3):377-91. PubMed ID: 3130365 [Abstract] [Full Text] [Related]